CDK12 Gene Alterations in Prostate Cancer: Present, but Clinically Actionable?

Eur Urol. 2020 Nov;78(5):680-681. doi: 10.1016/j.eururo.2020.04.007. Epub 2020 May 4.

Authors

Ariel E Marciscano¹, Christopher E Barbieri²

Affiliations

¹ Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
² Department of Urology, Weill Cornell Medical College, New York, NY, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA. Electronic address: chb9074@med.cornell.edu.

PMID: 32381460
DOI: 10.1016/j.eururo.2020.04.007

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cyclin-Dependent Kinases / genetics
Genes, cdc
Genomics
Humans
Male
Prostatic Neoplasms* / genetics

Substances

CDK12 protein, human
Cyclin-Dependent Kinases